- $130.40bn
- $142.76bn
- $56.14bn
- 83
- 67
- 73
- 86
2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 32,426 | 18,784 | 45,828 | 78,494 | 56,141 |
Cost of Revenue | |||||
Gross Profit | 15,380 | 6,362 | 22,104 | 37,517 | 26,473 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 23,679 | 20,867 | 34,159 | 52,088 | 41,113 |
Operating Profit | 8,747 | -2,083 | 11,669 | 26,406 | 15,028 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 9,524 | -3,140 | 12,712 | 28,228 | 16,288 |
Provision for Income Taxes | |||||
Net Income After Taxes | 7,257 | -2,655 | 8,079 | 18,680 | 10,957 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 7,189 | -2,701 | 8,079 | 18,680 | 10,957 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 7,189 | -2,707 | 8,060 | 18,620 | 10,922 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.15 | -1.83 | 6.35 | 14.1 | 8.97 |
Dividends per Share |